Lloyd Sems

Insider Reports History

Location
New York, NY
Signature
/s/ Lloyd Sems
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Lloyd Sems:

Company Role Class Num Shares Value Price $ Report Date Ownership
Cyclacel Pharmaceuticals, Inc. Director Common Stock 18,196 $60,320 $3.32 14 Jun 2022 Direct
Cyclacel Pharmaceuticals, Inc. Director Stock Option (right to buy) 31,645 14 Jun 2022 Direct

Insider Reports Filed by Lloyd Sems

Symbol Company Period Transactions Value $ Form Type Role Filing Time
CYCC Cyclacel Pharmaceuticals, Inc. 14 Jun 2022 2 $0 4 Director 16 Jun 2022, 16:11
CYCC Cyclacel Pharmaceuticals, Inc. 15 Jun 2021 2 $0 4 Director 17 Jun 2021, 16:08